Abstracts tagged "Ankylosing spondylitis (AS) and cardiovascular disease"

Abstract Number: 168 • 2016 ACR/ARHP Annual Meeting
Prevalence of Diastolic Dysfunction and Structural Heart Disease in Axial Spondyloarthritis: A Prospective Case Control Study Using Echocardiography
Risheen Reejhsinghani¹, Kathryn Becker², Nelson Schiller¹, Grace Yoon³, Elyse Foster¹ and Lianne S. Gensler⁴, ¹Cardiology, University of California, San Francisco, San Francisco, CA, ²Cardiology, Kelowna General Hospital, Kelowna, BC, Canada, ³Medicine/Rheumatology, University of California, San Francisco, San Franciscao, CA, ⁴Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA
Background/Purpose: The aim of our study was to describe the prevalence of diastolic dysfunction (DD) and structural heart disease (SHD) among a cohort of Axial…
Abstract Number: 1693 • 2015 ACR/ARHP Annual Meeting
High Prevalence of Cardiac Disease in Patients with Ankylosing Spondylitis
Sjoerd C. Heslinga¹, Thelma C. Konings², Otto Kamp², Mike J.L. Peters³, Yvo M. Smulders³, Irene E. Van der Horst - Bruinsma¹ and Mike T. Nurmohamed¹, ¹Rheumatology, Reade, Amsterdam Rheumatology and immunology Center, Amsterdam, Netherlands, ²Cardiology, VU University Medical Center, Amsterdam, Netherlands, ³Internal Medicine, VU University Medical Center, Amsterdam, Netherlands
Background/Purpose: Ankylosing spondylitis (AS) is associated with increased risk of concomitant cardiac disease, such as valvular regurgitation, conduction disturbances and decreased ventricular function (1). However,…
Abstract Number: 1698 • 2015 ACR/ARHP Annual Meeting
High Prevalence of Traditional Cardiovascular Risk Factors in an Ankylosing Spondylitis Cohort
Gillian Fitzgerald¹, Dara J Lundon², Phil Gallagher³, Claire Sheehy⁴, Catherine Sullivan⁵, Carmel Silke⁶, Frances Stafford⁷, Killian O Rourke⁸, Muhammad Haroon⁹, Ronan Mullan¹⁰, Oliver FitzGerald¹¹ and Finbar (Barry) O'Shea¹², ¹Rheumatology, St James's Hospital, Dublin 8, Ireland, ²School of Medicine, University College Dublin, Dublin, Ireland, ³Rheumatology, St. Vincent's University Hospital, Dublin, Ireland, ⁴University Hospital Waterford, Waterford, Ireland, ⁵Rheumatology, UCHG Ireland, Galway, Ireland, ⁶Rheumatology, Sligo University Hospital, Sligo, Ireland, ⁷Rheumatology, Blackrock Clinic, Co Dublin, Ireland, ⁸Rheumatology, Midlands Regional Hospital, Tullamore, Co Offaly, Ireland, ⁹Rheumatology, Kerry General Hospital, Co Kerry, Ireland, ¹⁰Department of Rheumatology, Tallaght Hospital, TCD, Dublin 24, Ireland, ¹¹St Vincent's University Hospital, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, St Vincent's University Hospital, Dublin 4, Dublin 4, Ireland, ¹²Rheumatology Dept, St James's Hospital, Dublin, Ireland
Background/Purpose: Patients with Ankylosing Spondylitis (AS) have previously been considered an otherwise healthy patient population. However, emerging evidence suggests AS is an independent risk factor…
Abstract Number: 2583 • 2014 ACR/ARHP Annual Meeting
Unexpected High Prevalence of Cardiac Disease in Patients with Ankylosing Spondylitis
S.C. Heslinga^1,2, Thelma C. Konings³, Irene E. Van der Horst - Bruinsma⁴, M.L. John⁴ and Mike T. Nurmohamed², ¹Internal Medicine, VU University Medical Center, Amsterdam, Netherlands, ²Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, ³Cardiology, VU University Medical Center, Amsterdam, Netherlands, ⁴Rheumatology, VU University Medical Center, Amsterdam, Netherlands
Background/Purpose Ankylosing spondylitis (AS) is associated with an increased cardiovascular (CV) risk that is caused by accelerated atherosclerosis as well as specific cardiac manifestations: valvular…
Abstract Number: 2454 • 2013 ACR/ARHP Annual Meeting
High Prevalence Of Left Ventricular Diastolic Dysfunction In Patients With Ankylosing Spondylitis
Sjoerd C. Heslinga^1,2, Thelma C. Konings³, Irene E. Van der Horst-Bruinsma^4,5 and Michael T. Nurmohamed^1,2, ¹Rheumatology, VU University Medical Center, Amsterdam, Netherlands, ²Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, ³Cardiology, VU University Medical Center, Amsterdam, Netherlands, ⁴Department of Rheumatology, VU University Medical Center, Amsterdam, Netherlands, ⁵Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands
Background/Purpose: Patients with ankylosing spondylitis (AS) have an increased cardiovascular risk leading to decreased life expectancy. This is due to both accelerated atherosclerotic disease as…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].